Ampio Pharm (AMPE) Peer Comparison

$0.18

$-0.44 (-70.47%)

As on 05-Jun-2026 09:30EDT

Market cap

$0 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.1

Div. Yield

0 %

Edit

	Ampio Pharm (AMPE)	NovaBay Pharmaceuticals (NBY)	Finch Therapeutics Group (FNCH)
Market cap ($ Mln)	0	52	15
Revenue ($ Mln)	--	2	6
Net Profit ($ Mln)	-8.63	522.59	-13.88
Net Margin (%)	-3,523.27	21,217.70	-248.98
RoE (%)	-113.96	744.12	-86.83
Price to Earnings	--	--	--
Price-To-Book	0.09	0.24	0.84

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Ampio Pharm (AMPE)	NovaBay Pharmaceuticals (NBY)	Finch Therapeutics Group (FNCH)
Operating Revenue	0.00	10.46	0.11
Cost of Revenue	0.25	4.37	1.52
Gross Profit	-0.25	6.08	-1.41
Operating Expenses	9.27	10.19	32.59
Operating Profit (EBIT)	-9.52	-4.10	-34.00
Other Income	--	--	--
Profit before Tax	-8.63	-6.15	-78.22
Provision for Tax	--	0.04	-3.46
Profit after Tax (Net Income)	-8.63	-9.64	-74.75
Minority Interest	--	--	--
Consolidated Profit	--	-16.70	--

Liabilities ($ Mln)

	Ampio Pharm (AMPE)	NovaBay Pharmaceuticals (NBY)	Finch Therapeutics Group (FNCH)
Shareholder's Funds	3.36	3.31	22.89
Minority Interest	--	--	--
Non-Current Liabilities	0.00	1.44	28.40
Current Liabilities	2.38	4.28	4.08
Total Liabilities	5.74	9.03	55.37

Assets ($ Mln)

	Ampio Pharm (AMPE)	NovaBay Pharmaceuticals (NBY)	Finch Therapeutics Group (FNCH)
Non-Current Assets	0.14	1.88	29.53
Current Assets	5.74	7.15	25.85
Total Assets	5.74	9.03	55.37
Total Debt*	0.27	2.74	30.13
Net Current Assets	3.36	2.88	21.76

Cashflow ($ Mln)

	Ampio Pharm (AMPE)	NovaBay Pharmaceuticals (NBY)	Finch Therapeutics Group (FNCH)
Cash From Operating Activities	-8.56	-4.26	-31.51
Cash Flow from Investing Activities	--	-0.02	1.33
Cash from Financing Activities	0.10	1.91	-16.16
Net Cash Inflow / Outflow	--	--	--

Ratios

Profitability Ratios

	Ampio Pharm (AMPE)	NovaBay Pharmaceuticals (NBY)	Finch Therapeutics Group (FNCH)
ROCE (%)	-106.40	-103.38	-74.36
ROE (%)	-113.96	-139.03	-126.06
ROA (%)	-89.34	-75.81	-68.48
EBIT Margin (%)	--	--	--
Net Margin (%)	--	-92.20	-69,863.55
Cash Profit Margin (%)	--	--	--

Growth Ratios

	Ampio Pharm (AMPE)	NovaBay Pharmaceuticals (NBY)	Finch Therapeutics Group (FNCH)
Revenue Growth (%)	--	-0.27	-0.88
EBIT Growth (%)	--	--	--
Net Profit Growth (%)	47.16	9.13	34.80
EPS Growth (%)	0.52	-0.75	0.35
Book Value Growth (%)	--	--	--

Valuation Ratios

	Ampio Pharm (AMPE)	NovaBay Pharmaceuticals (NBY)	Finch Therapeutics Group (FNCH)
Price / Earnings	-0.20	-0.02	-0.08
Price / Book Value	0.51	0.06	0.25
Dividend Yield (%)	--	--	--
EV/EBITDA	0.26	0.05	-0.33
Market Cap ($ Cr)	--	--	--

Solvency Ratios

	Ampio Pharm (AMPE)	NovaBay Pharmaceuticals (NBY)	Finch Therapeutics Group (FNCH)
Debt to Equity	0.08	0.83	1.32
Short term debt to equity ratio	0.08	0.49	0.15
Current Ratio	2.41	1.67	6.33
Quick Ratio	2.41	1.00	--
Interest Coverage	--	-2.63	--

Operating Efficiency Ratios

	Ampio Pharm (AMPE)	NovaBay Pharmaceuticals (NBY)	Finch Therapeutics Group (FNCH)
Debtors to sales (%)	--	7.26	0.00
Asset Turnover	0.00	0.82	0.00
Receivable days	--	48.47	245.78
Inventory Days	0.00	263.81	-844.16
Payable days	618.73	92.34	148.74
Cash Conversion Cycle	--	219.94	-747.13

Annual
Quarterly